Filter
Period
Filter by
recent search
Showing: 1 – 05 of 123 Regulated Information
–
01 December 2020
01 December 2020
–
22 October 2020
22 October 2020
Ipsen delivers sales growth in the first nine months of 2020 despite the impact of COVID-19 and confirms its 2020 full year guidance
Paris (France), 22 October 2020 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced sales for the third quarter of 2020.
–
22 April 2020
22 April 2020
Ipsen reports solid sales growth in first quarter 2020 with limited COVID-19 impact
Paris (France), 22 April 2020 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced its sales for the first quarter of 2020.
–
13 February 2020
13 February 2020
Ipsen presents its 2019 results, provides 2020 guidance and updates 2022 financial outlook
Paris (France), 13 February 2020 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced its financial results for the full year 2019.
–
24 October 2019
24 October 2019